These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 11857301)
1. Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence. Velasco A; Hewitt SM; Albert PS; Hossein M; Rosenberg H; Martinez C; Sagalowsky AI; McConnell JD; Marston W; Leach FS Cancer; 2002 Feb; 94(3):690-9. PubMed ID: 11857301 [TBL] [Abstract][Full Text] [Related]
2. Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer. Prtilo A; Leach FS; Markwalder R; Kappeler A; Burkhard FC; Cecchini MG; Studer UE; Thalmann GN J Urol; 2005 Nov; 174(5):1814-8; discussion 1818. PubMed ID: 16217293 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic implications of hMSH2 gene expression and microsatellite instability in prostate cancer. Velasco A; Albert PS; Rosenberg H; Martinez C; Leach FS Cancer Biol Ther; 2002; 1(4):362-7. PubMed ID: 12432247 [TBL] [Abstract][Full Text] [Related]
4. Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer. Burger M; Denzinger S; Hammerschmied CG; Tannapfel A; Obermann EC; Wieland WF; Hartmann A; Stoehr R J Mol Med (Berl); 2006 Oct; 84(10):833-41. PubMed ID: 16924473 [TBL] [Abstract][Full Text] [Related]
5. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP. Leach FS; Velasco A; Hsieh JT; Sagalowsky AI; McConnell JD J Urol; 2000 Nov; 164(5):1830-3. PubMed ID: 11025778 [TBL] [Abstract][Full Text] [Related]
6. Defective mismatch repair and the development of recurrent endometrial carcinoma. Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer. Wilczak W; Rashed S; Hube-Magg C; Kluth M; Simon R; Büscheck F; Clauditz TS; Grupp K; Minner S; Tsourlakis MC; Möller-Koop C; Graefen M; Adam M; Haese A; Wittmer C; Sauter G; Izbicki JR; Huland H; Schlomm T; Steurer S; Krech T; Lebok P Carcinogenesis; 2017 Jan; 38(1):19-27. PubMed ID: 27803051 [TBL] [Abstract][Full Text] [Related]
9. Loss of DNA mismatch repair proteins in prostate cancer. Sharma M; Yang Z; Miyamoto H Medicine (Baltimore); 2020 May; 99(19):e20124. PubMed ID: 32384491 [TBL] [Abstract][Full Text] [Related]
10. Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. Scartozzi M; Bianchi F; Rosati S; Galizia E; Antolini A; Loretelli C; Piga A; Bearzi I; Cellerino R; Porfiri E J Clin Oncol; 2002 Mar; 20(5):1203-8. PubMed ID: 11870161 [TBL] [Abstract][Full Text] [Related]
11. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder. Jin TX; Furihata M; Yamasaki I; Kamada M; Liang SB; Ohtsuki Y; Shuin T Cancer; 1999 Jan; 85(2):478-84. PubMed ID: 10023718 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Catto JW; Xinarianos G; Burton JL; Meuth M; Hamdy FC Int J Cancer; 2003 Jul; 105(4):484-90. PubMed ID: 12712438 [TBL] [Abstract][Full Text] [Related]
13. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy. Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer. Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659 [TBL] [Abstract][Full Text] [Related]
15. hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037 [TBL] [Abstract][Full Text] [Related]
16. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma. Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876 [TBL] [Abstract][Full Text] [Related]
17. Defects of DNA mismatch repair in human prostate cancer. Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder. Mylona E; Zarogiannos A; Nomikos A; Giannopoulou I; Nikolaou I; Zervas A; Nakopoulou L APMIS; 2008 Jan; 116(1):59-65. PubMed ID: 18254781 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Dietmaier W; Wallinger S; Bocker T; Kullmann F; Fishel R; Rüschoff J Cancer Res; 1997 Nov; 57(21):4749-56. PubMed ID: 9354436 [TBL] [Abstract][Full Text] [Related]
20. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]